NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Luminoma Diagnostics

Luminoma Diagnostics

Private
AucklandHealthcare & Life Scienceshttps://www.luminomadx.com/

Last Round

Series A

Jul 1, 2026

Total Funding Raised

$8.82M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Luminoma Diagnostics is a diagnostic equipment company that develops a portable, non-invasive device using Raman spectroscopy and machine learning to aid clinicians in the early detection of skin cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

early cancer detectionnon-invasive diagnosticsmolecular diagnostic testingbiopsy alternativeRaman spectroscopybiomarker identificationclinical AIchemometricsoncology diagnosticmedtechdigital pathologydiagnostic deviceAI-powered diagnosticsclinical decision supportdermatology diagnostic

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Luminoma Diagnostics Comparables

Compare Luminoma Diagnostics with similar companies based on industry and business-model similarity.

Luminoma Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GRAIL
70%
Guardant Health
67%
DermTech, LLC
59%

Luminoma Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 1, 2026
SeedDec 8, 2025
CrowdfundingAug 13, 2025
SeedJun 6, 2024

Key People

Founding team and executive leadership

Maher Khaled

CEO

Executive Team

Luminoma Diagnostics Investors

Notable investors and investment history

Luminoma Diagnostics investors
InvestorRounds
Catalist Nominee LimitedCrowdfunding
Bridgewest VenturesCrowdfunding, Seed
Angel HQSeed
Pacific ChannelCrowdfunding, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    $9M round completed.

  • Aug 13, 2025

    $860K raised from Bridgewest Ventures and Pacific Channel.

Luminoma Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Luminoma Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Luminoma Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAuckland
Employee Range7
Year Founded2023
Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.